-
Services
Featured Specialties
-
Locations
Location Type
-
Patients & Visitors
Sandip Mukherjee, MD, and Jaime Gerber, MD, lead the Executive Health Program care team of renowned physician specialists and administrative staff. They are available to answer any questions about the program.
Sandip Mukherjee, MD, is a cardiologist at Yale Medicine who specializes in treating and preventing conditions such as hypertension and aortic aneurysms. Dr. Mukherjee’s focus is on identifying risk factors of coronary artery disease, one of the most common causes of heart attack. In addition to seeing patients, Dr. Mukherjee conducts clinical research to investigate safer and more effective ways of treating heart diseases. Dr. Mukherjee is an associate professor of medicine at Yale School of Medicine.
Jaime Gerber, MD, subspecializes in preventive cardiology and diagnoses and treats a range of conditions including coronary artery disease, high cholesterol, and peripheral vascular disease. He directs the Yale New Haven Heart and Vascular Center laboratory for vascular ultrasound testing for peripheral arterial disease and consults on complex cardiology cases that involve coronary artery disease, peripheral artery disease, and risk factor modification. Dr. Gerber is an associate professor of clinical medicine at Yale School of Medicine.
Additional members of the Executive Health Program care team include:
Eric Bader, MD, is a cardiologist who specializes in electrophysiology – the management of heart rhythm disorders. Dr. Bader’s clinical practice includes the implantation and management of cardiac devices for the prevention of sudden cardiac death, and cardiac resynchronization therapy to treat heart failure. He performs extractions of infected and malfunctioning pacemakers and defibrillators, as well as complex ablations of a broad spectrum of arrhythmias. Dr. Bader is board-certified in internal medicine, cardiovascular diseases, clinical cardiac electrophysiology, echocardiography, nuclear cardiology and vascular imaging.
Mehra Golshan, MD, MBA, is a cancer surgeon and a leader in breast cancer care on a national and international level. In addition to caring for Yale Medicine patients, he serves as Deputy Chief Medical Officer for Surgical Services and Clinical Director of the Breast Cancer Program for the Yale Cancer Center, Smilow Cancer Hospital, and Executive Vice Chair in the Department of Surgery. He is responsible for coordinating and expanding cancer surgery services throughout Yale New Haven Health and the Smilow network. Dr. Golshan’s approach to breast cancer treatment is through a specialized team approach. For each new patient, Smilow brings together a team of medical oncologists, radiation oncologists, reconstruction surgeons, pathologists, genetics, breast imagers, radiologists, program nurses, and a robust clinical research program.
Christopher Gottschalk, MD, established the Headache Medicine program at Yale Medicine and treats patients with chronic migraine and related headaches, as well as headaches due to issues such as head injury (concussion), elevated spinal fluid pressure (pseudotumor cerebri or IIH), and low-pressure (SIH due to spinal CSF leaks). He is director of the Concussion Program and lead neurologist of the Facial Pain Board at Yale Medicine. In addition, Dr. Gottschalk is a professor of neurology at Yale School of Medicine. His clinical research focuses on treatments designed to reduce the frequency and severity of migraine and other primary headache disorders, and ways to optimize interventions to improve headache diagnosis and management across medical specialties.
David Hafler, MD, is a world-renowned expert on multiple sclerosis (MS) and chair of the Department of Neurology, where he has presided over a major expansion in the last several years. A professor of neurology and of immunobiology at Yale School of Medicine, Dr. Hafler is also a prolific researcher whose work has led to major advances in the understanding and treatment of MS, including identification of it as an autoimmune and genetic disease. He leads a lab at Yale that conducts cutting-edge research into MS and develops new treatments.
Benjamin Judson, MD, is the chief of the Yale School of Medicine Division of Otolaryngology. Dr. Judson specializes in performing surgery to remove benign and malignant tumors of the head and neck and was the first in New England to perform transoral robotic surgery. He routinely operates on complex and difficult cases in collaboration with a multidisciplinary team that may include surgical and radiation oncologists, and other specialties involved in the patient’s treatment plan. Dr. Judson is a professor of otolaryngology at Yale School of Medicine, and his research focuses on investigating outcomes and quality in head and neck cancer therapy. He started a tumor biorepository that supports multiple laboratory investigations of head and neck cancer at Yale and other institutions around the world.
Jonathan Leventhal, MD, is the director of the Onco-Dermatology Program at Smilow Cancer Hospital in New Haven. He treats patients undergoing cancer treatment who experience itchy or painful rashes, as well as hair and nail changes that can result from their treatment. He is renowned for his expertise in diagnosing and treating skin cancer as well as other debilitating skin conditions from psoriasis to eczema. Dr. Leventhal is an associate professor of dermatology at Yale School of Medicine and a Principal Investigator of several clinical trials investigating novel treatments for cutaneous reactions to cancer therapy.
Thomas Martin, MD, is a urologist and expert surgeon in the use of minimally invasive surgical approaches to urologic cancers, urinary tract/kidney stone disease and prostate disease. He treats patients with prostate and kidney cancer, and benign prostatic hyperplasia (BPH), and was involved in the establishment of the first robotic surgery program in Southern Connecticut. Dr. Martin is an associate professor of urology, as well as executive vice chair and vice chair of Clinical Affairs, urology, at Yale School of Medicine. He has won awards for teaching from both the urology residents and physician assistants at Yale New Haven Hospital.
Elena Ratner, MD, is a gynecologic oncologist specializing in ovarian malignancies. An advocate for cancer survivors, she is also co-founder and director of the Yale Medicine Sexual, Intimacy and Menopause Program (SIMS), one of the first programs in the country to focus on supporting cancer survivors coping with issues that may not be discussed in the other clinical settings. Dr. Ratner is a professor of obstetrics, gynecology and reproductive sciences at Yale School of Medicine. Her clinical research focuses on new targeted drugs for ovarian cancer that will provide truly personalized care, and on reversing chemotherapy resistance in ovarian and uterine cancers. She also studies chemotherapy targeted drug development, quality-of-life programs for patients and early cancer detection. Dr. Ratner is a recipient of multiple awards, including the 2015 Yale Cancer Center Award for Clinical Excellence.
Lee Eric Rubin, MD, is both the section chief of the division of adult reconstruction at Yale School of Medicine and chief of the total joint replacement program at Yale New Haven Hospital. He is a board-certified orthopaedic surgeon and a nationally known expert in the direct anterior approach procedure for hip replacement. His expertise includes joint preservation techniques, partial and total joint replacements, and revisions. Dr. Rubin cares for patients who have prosthetics such as artificial joints that may be failing or complicated by pain, a dislocation, or an infection. Dr. Rubin is an associate professor of orthopaedics and rehabilitation, as well as program director of the Yale Arthroplasty Fellowship, at Yale School of Medicine.
Joseph Schindler, MD, is the clinical chief of Stroke and Vascular Neurology at the Yale School of Medicine and the director of the Comprehensive Stroke Center at Yale New Haven Hospital. Dr. Schindler is board-certified in both neurology and vascular neurology. He treats patients for stroke and diseases that affect the supply of blood to the brain, spinal cord and retina. Dr. Schindler is a professor of neurology and neurosurgery at Yale School of Medicine.
Jonathan Siner, MD, is the clinical section chief of Pulmonary, Critical Care and Sleep Medicine, and specializes in quality and safety work and treating interstitial lung disease (ILD), or diseases that cause lung scarring. He is the chair of the Yale New Haven Health System Intensive Care Unit (ICU) Committee and medical director of the Tele-ICU. He recently completed 11 years directing the Yale New Haven Hospital (YNHH) Medical Intensive Care Unit (MICU). Dr. Siner’s research interests include low-tidal volume ventilation for ARDS (acute respiratory distress syndrome), and he practices in the ambulatory arena seeing patients with Interstitial Lung Disease. In 2019, Dr. Siner received Yale Medicine’s Excellence in Quality and Safety Award.
